Jade Biosciences (NASDAQ:JBIO) Stock Price & Analysis

–

USD

–(–)

Open

$21.42

Prev. Close

$19.14

High

$22.26

Low

$21.06

Company Profile

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.

CEOTom Frohlich

SectorHealthcare

IndustryBiotechnology

Employees55

IPO DateJun 30, 2021

ExchangeNASDAQ

Exchange NameNASDAQ Global Market

CurrencyUSD

Headquarters & Contact

AddressBuilding 23

City / State / ZIPWaltham, MA, 02453

CountryUnited States

Phone1 916-322-1700

Websitehttps://jadebiosciences.com

Jade Biosciences, Inc.

Company Profile

Recently from Cashu